Indonesia Testing Location for China’s Sinovac Phase 3 Clinical Trial

Sinovac, one of the leading COVID-19 vaccine developers, initiated Phase 3 clinical trial in Indonesia where about 800 participants have registered for the clinical trial. Led by Padjajaran University (Unpad), Medical School’s Kusnandi Rusmil reports the clinical trial will commence on August 11. Thus far, they have only met half of their target in terms of a total of 1,620 volunteers. Volunteer registrations continue through at least until August 31.


